November 8, 2019

Healthcare Artificial Intelligence: Emerging Trends and Future Demands

Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare for approximation of human cognition and analysis of complex medical and diagnostic imaging data.

DOWNLOAD PDF SAMPLE

Artificial intelligence has revolutionized the healthcare industry by designing treatment plans, medication management, assisting in repetitive tasks, and drug discovery. Increasing adoption of precision medicine has made enabled simplicity of management and cost reduction. Increasing application in genomics research coupled with incremental innovation in robotic personal digital assistants boost industry growth.

North America is expected to be the largest and fastest-growing region in healthcare artificial intelligence market during the forecast period. The regulatory mandates for the use of Electronic Health Records (EHR), increasing focus on precision medicine, and strong presence of leading companies engaged in developing AI solutions for healthcare, and huge number of cross-industry collaborations and growing investments in the field of AI in healthcare are driving the growth of the market in North America.

GET MORE INFORMATION

The report also includes the profiles of key healthcare artificial intelligence market players along with their SWOT analysis and growth strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Some of the key players influencing the market are IBM Corporation, NVIDIA Corporation, Microsoft, iCarbonX, Next IT Corp., CloudMedx Inc., Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., and Medtronic.